PeerVoice Heart & Lung Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 19m. Bisher sind 228 Folge(n) erschienen. .

Gesamtlänge aller Episoden: 3 days 15 hours 1 minute

subscribe
share






Wytske Fokkens, MD, PhD - Biologics for CRSwNP Management: Your Questions Answered


Wytske Fokkens, MD, PhD - Biologics for CRSwNP Management: Your Questions Answered


share








 November 15, 2022  21m
 
 

Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022


Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022


share








 October 28, 2022  23m
 
 

Javed Butler, MD, MPH, MBA - Changing the Patient Journey Across the Spectrum of Heart Failure


Javed Butler, MD, MPH, MBA - Changing the Patient Journey Across the Spectrum of Heart Failure


share








 October 21, 2022  22m
 
 

Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice


Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice


share








 October 4, 2022  24m
 
 

Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC


Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC


share








 September 30, 2022  27m
 
 

Hot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC


Hot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC


share








 September 21, 2022  24m
 
 

New Biomarkers, New Targets in Advanced NSCLC


New Biomarkers, New Targets in Advanced NSCLC


share








 August 18, 2022  20m
 
 

Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC


Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC


share








 July 12, 2022  37m
 
 

Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022


Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022


share








 July 1, 2022  19m
 
 

Evolving Clinical Management of the Hospitalised COVID-19 Patient


Evolving Clinical Management of the Hospitalised COVID-19 Patient


share








 May 31, 2022  27m